Background {#Sec1}
==========

In June 2015, an outbreak of porcine dermatitis and nephropathy syndrome (PDNS) was reported in a commercial pig farm in North Carolina, United States. Compared with the historical data, the mortality rate of sows increased by 10.2% and the pregnancy rate dropped 0.6%. The affected sows were anorexic and their skin presented multifocal papules, plaques and superficial dermatitis. The manifestation of infected foetuses included weak, stillborn and mummified individuals. A new virus was isolated from these animals with the help of next-generation sequencing technology and was identified as porcine circovirus 3 (PCV3) \[[@CR1]\]. PCV3 was subsequently widely detected in China, Korea, Brail and many other European countries including Poland, Italy, Spain, Denmark, Germany, and the United Kingdom \[[@CR2]--[@CR6]\].

Porcine circovirus 3 (PCV3) is a member of the *Circovirus genus* in the *Circoviridae* family. The clinical symptoms and pathological changes of PCV3-infected pigs were highly similar to those of PCV2-infected pigs \[[@CR7]\]. Given that the virus may be highly prevalent globally, an accurate laboratory diagnosic for rapid confirmation of PCV3 infection is needed. Recently, conventional loop-mediated isothermal amplification (LAMP) assays and PCR-based diagnostic assays for PCV3 have been developed \[[@CR8]--[@CR10]\]. Real-time LAMP is a constant temperature amplification method carried out at 60--65 °C, for which only a simple water bath is required. Real-time LAMP eliminates reverse transcription steps as well as PCR instrument cooling time, which shortens the amplification time. Adding a fluorescent DNA intercalating dye into the real-time LAMP reaction enables monitoring of a fluorescence amplification curve \[[@CR11]\]. Compared to conventional LAMP assays, this method avoids visible error, enables quantitative detection and is more suitable for multi-sample analysis. Because of its simple reaction conditions and ease of use, the real-time LAMP method has been adapted for the detection and diagnosis of a variety of pathogens \[[@CR12], [@CR13]\]. In this study, a real time RT-LAMP assay was developed for the rapid diagnosic of PCV3.

Results {#Sec2}
=======

Sensitivity and specificity of the real-time LAMP assay for rapid detection of PCV3 {#Sec3}
-----------------------------------------------------------------------------------

Ten-fold serial dilutions of plasmid DNA were used as templates in the assay. The detection limit of the assay was 1 × 10^1^ copies/μL per reaction (Fig. [1](#Fig1){ref-type="fig"}). These results indicated the real-time LAMP assay could be used as a sensitive diagnostic test for PCV3. Fig. 1Sensitivity of the LAMP assay for PCV3. Ten-fold serial dilutions of plasmids containing a cloned fragment of the PCV3 capsid gene were used for the assay. Negative control, H~2~O. All reactions were performed in duplicate

The specificity of the reactions was identified using DNA templates of PCV2, PCV3, PRV and other swine viral cDNA samples including those of CSFV, FMDV, PEDV, and PRRSV. The experiment was performed in duplicate. All reactions containing PCV3 were positive in the real-time LAMP assay. The other viral samples mentioned above were negative, indicating that the assay was highly specific for PCV3 (Fig. [2](#Fig2){ref-type="fig"}). Fig. 2Specificity of the LAMP assay. DNA from PCV2, PRV and cDNA of other swine viral pathogens including FMDV, PEDV, CSFV and PRRSV was tested in the LAMP assay. H~2~O was used as template for mock samples. All reactions were performed in duplicate

Clinical sample testing {#Sec4}
-----------------------

The real-time LAMP were performed to test for PCV3 DNA in 203 clinical samples as previously described \[[@CR10]\]. The PCV3-positive rate detected by the real-time LAMP was 89.66% (182/203) (Table [1](#Tab1){ref-type="table"}). Table 1Screening results for 203 clinical samples for real time LAMP, real-time PCR and conventional PCR assayMolecular techniqueSamplesProportion positiveBrainHeartLiverSpleenLungKidneySerumReal time LAMP24/3626/2932/3429/3132/3429/2910/1089.66%(182/203)Real-time PCR23/3626/2929/3429/3132/3427/2910/1086.70%(176/203)Conventional PCR6/3611/297/348/319/349/294/1026.6%(54/203)

Discussion {#Sec5}
==========

In this study, a novel real-time LAMP assay for detecting PCV3 was developed, and 203 clinical samples were used to validate the field application of the assay. This assay introduces a new method for the laboratory detection of PCV3 that does not rely on expensive equipment and instrumentation. Thus, the real-time LAMP assay established in this study is a valuable alternative for the detection of PCV3.

To the best of our knowledge, this method is the first real-time LAMP assay for the PCV3 detection, which has a detection limit of 1 × 10^1^ copies/μL for PCV3, and is more sensitive than regular PCR. According to previous reports, the limit of detection of PCV3 was 1.73 × 10^2^ copies/μL and 10^2^ copies/μL with a SYBR Green-based real-time quantitative PCR assay and a TaqMan-based real-time PCR assay, respectively \[[@CR9], [@CR10]\]. In this real-time LAMP study, the detection limit was only approximately 1 × 10^1^ copies/μL. Both real-time LAMP and conventional PCR \[[@CR1]\] were performed to demonstrate the presence of PCV3 DNA in samples as previously described \[[@CR10]\]. The PCV3-positive rates detected by conventional PCR, real-time quantitative PCR and real-time LAMP were 26.60% (54/203) \[[@CR10]\], 86.70% (176/203) \[[@CR10]\], and 89.66% (182/203), respectively. Furthermore, the samples that were positive for PCV3 by the real-time LAMP assay but negative by the conventional PCR assay were confirmed by the nested PCR (S1) \[[@CR14]\]. Positive PCR products were confirmed by sequencing (S2). These results demonstrate that the real-time LAMP assay was sufficient, accurate and reliable as a molecular diagnostic test for the detection of PCV3.

Conclusion {#Sec6}
==========

A novel real-time LAMP assay was developed in this study for the detection of PCV3 nucleic acids. This PCV3 real time LAMP assay was highly specific, sensitive and reliable. This assay will be useful for the diagnosis and epidemiological and pathogenesis studies of PCV3 infections.

Methods {#Sec7}
=======

Virus strains and clinical samples {#Sec8}
----------------------------------

Clinical samples including 36 brains, 29 hearts, 34 livers, 31 spleens, 34 lungs, 29 kidneys and 10 sera from pigs from a previous experiment that were stored at Jingyun Ma's lab (South China Agricultural University, Guangzhou, China) were subjected to a real-time LAMP assay \[[@CR10]\]. Six porcine viruses were used for specificity testing of PCV3. These viruses were classical swine fever virus (CSFV) C strain, foot-and-mouth disease virus (FMDV), porcine circovirus 2 (PCV2) LG vaccine strain, porcine epidemic diarrhoea virus (PEDV), porcine respiratory and reproductive syndrome virus (PRRSV), and pseudorabies virus (PRV) \[[@CR13], [@CR15]\].

Nucleic acid extraction {#Sec9}
-----------------------

Frozen field samples were homogenized for 30 s with a tissue homogenizer in phosphate-buffered saline (PBS) to prepare samples for extraction procedures. Viral DNA and RNA were extracted from the samples using a TGUide Virus DNA/RNA Kit and T-Guide instrument according to the manufacturer's instructions (Tiangen, Beijing, China). The RNA viruses were treated with a PrimeScript™ RT reagent Kit with gDNA Eraser kit (Takara, China) according to the manufacturer's instructions.

Design of primers for real-time LAMP {#Sec10}
------------------------------------

Real-time LAMP primers targeting on the PCV3 cap gene (accession number KY418606.1) were designed using the program <http://primerexplorer.jp> and were synthesized by Sangon (Sangon Biotech, Shanghai, China). The primers included two inner primers (PCV3-FIP and PCV3-BIP) and two outer primers (PCV3 -F3 and PCV3-B3) (Table [2](#Tab2){ref-type="table"}). Table 2Oligonucleotide primers used in this studyNameSequence((5′--3′) and PositionPCV3-B3GCAGTGCTCCCCATTGAAC (1425--1443)PCV3-F3ACACTTGGCTCCAAGACGA (1610--1628)PCV3-BIPGAACTACCAGCGCTCACCCAG (1503--1520)-GGTGGGGTCATATGTGTTGA (1444--1463)PCV3-FIPTGGGGGTGAAGTAACGGCTGT (1539--1559)-TGCGGAAAGTTCCACTCGTA (1584--1603)PCV3-LBTTTCTCCAGACCCACCCCATG (1466--1486)

Construction of plasmids containing the cap gene of PCV3 {#Sec11}
--------------------------------------------------------

The target fragment was amplified using primers PCV3-F3 and PCV3-B3 and cloned into the pMD-18 T vector (Takara, China), which was transformed into *Escherichia coli* competent cells according to the manufacturer's instructions (DH5α, Tiangen, Beijing, China). The plasmid containing the PCV3 cap gene (pMD-18 T-cap) was purified using a commercial kit (Tiangen, Beijing, China). The concentration of the plasmid sample was determined by measuring the absorbance at 260 nm, using a NanoDrop Lite spectrophotometer (Thermo Scientific, USA), and the copy number of the cloned gene was quantified as follows \[[@CR16]\]: \[copies/μL = concentration of plasmid (g/μL)/\[(plasmid length× 660) × (6.022 × 10^23^)\].

Development of real-time LAMP assay {#Sec12}
-----------------------------------

The real-time LAMP reaction mixture contained template DNA or cDNA, inner primers (FIP and BIP) at 1.6 mM, outer primers (F3 and B3) at 0.2 mM, loop backward primers (LB) at 0.8 mM, 1 μL of Bst DNA polymerase (M5038 L, New England Biolabs, MA, USA), betaine at 0.8 M (BCBS087V, Sigma St. Louis, MO USA), dNTPs at 1.4 mM, 2.5 μL of amplification buffer (B0537S, New England Biolabs), 8 mM of MgSO~4~ and SYTO-9 green fluorescent nucleic acid stain at 0.1 mM (S34854, Invitrogen, Carlsbad, CA, USA). Double-distilled water was used as a negative control. The mixture was incubated at 63 °C for 60 min and then heated at 80 °C for 10 min to terminate the reaction. Finally the results were detected using a Thermostatic Fluorescence Detector (DEAOU-308C, Diao, Guangzhou, China) and are shown by the graph. Specificity of the method was determined using DNA templates of PCV2, PCV3, PRV and other swine viral cDNA samples from CSFV, FMDV, PEDV, and PRRSV. Ten-fold serial dilutions of pMD-18 T-cap were used to calculate the analytical sensitivity. The method was further evaluated using 203 clinical samples \[[@CR10]\]. H~2~O was used as template for mock samples. All reactions were performed in duplicate.

CSFV

:   Classical swine fever virus

FMDV

:   Foot-and-mouth disease virus

PCV2

:   Porcine circovirus 2

PCV3

:   Porcine circovirus type 3

PDNS

:   Porcine dermatitis and nephropathy syndrome

PEDV

:   Porcine epidemic diarrhoea virus

PRRSV

:   Porcine respiratory and reproductive syndrome virus

PRV

:   Pseudorabies virus
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